Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: Tilting the balance towards proinflammatory and pro-apoptotic subsets

Clinical and Experimental Immunology

Volumn 179, Issue 3, 2015, Pages 520-528

  Espinosa Ortega, F ^a   Gomez Martin D ^a   Santana De Anda, K ^a   Romo Tena, J ^a   Villasenor Ovies P ^a   Alcocer Varela, J ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

CD28null cells; Idiopathic inflammatory myopathies; Regulatory T cells; Tfh cells; Th17 cells

Indexed keywords

AZATHIOPRINE; CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; CREATINE KINASE; HYDROXYCHLOROQUINE; INTERLEUKIN 17; METHOTREXATE; TRANSCRIPTION FACTOR FOXP3; CCR6 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; CXCR3 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DENSITY GRADIENT CENTRIFUGATION; DERMATOMYOSITIS; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MUSCLE TISSUE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; TILTING; APOPTOSIS; HOMEOSTASIS; IMMUNOLOGY; IMMUNOPHENOTYPING; INFLAMMATION; METABOLISM; MIDDLE AGED; MUSCLE; MYOSITIS; PATHOLOGY;

ADULT; ANTIGENS, CD; APOPTOSIS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HOMEOSTASIS; HUMANS; IMMUNOPHENOTYPING; INFLAMMATION; MALE; MIDDLE AGED; MUSCLES; MYOSITIS; RECEPTORS, CCR6; RECEPTORS, CXCR3; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84922788450     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12475     Document Type: Article

References (40)

1. Brandao M, Marinho A. Idiopathic inflammatory myopathies: definition and management of refractory disease. Autoimmun Rev 2011; 10:720-724.
2. Furst DE, Amato AA, Iorga SR, Gajria K, Fernandes AW. Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve 2012; 45:676-683.
3. Fernandez C, Bardin N, De Paula AM etal. Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis. Medicine (Balt) 2013; 92:15-24.
4. Linklater H, Pipitone N, Rose MR etal. Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria. Clin Exp Rheumatol 2013; 31:767-769.
5. Venalis P, Lundberg IE. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy. Rheumatology 2014; 53:397-405.
6. Walsh RJ, Kong SW, Yao Y etal. Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum 2007; 56:3784-3792.
7. Selva-O'Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martinez-Gomez X, Vilardell-Tarres M. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 2006; 55:791-798.
8. Greenberg SA, Bradshaw EM, Pinkus JL etal. Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology 2005; 65:1782-1787.
9. Kondo M, Murakawa Y, Harashima N, Kobayashi S, Yamaguchi S, Harada M. Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathies. Immunology 2009; 128:e589-599.
10. Chevrel G, Page G, Granet C, Streichenberger N, Varennes A, Miossec P. Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J Neuroimmunol 2003; 137:125-133.
11. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010; 11:7-13.
12. Waschbisch A, Schwab N, Ruck T, Stenner MP, Wiendl H. FOXP3+ T regulatory cells in idiopathic inflammatory myopathies. J Neuroimmunol 2010; 225:137-142.
13. Fasth AE, Dastmalchi M, Rahbar A etal. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J Immunol 2009; 183:4792-4799.
14. Linterman MA, Rigby RJ, Wong RK etal. Follicular helper T cells are required for systemic autoimmunity. J Exp Med 2009; 206:561-576.
15. Morita R, Schmitt N, Bentebibel SE etal. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011; 34:108-121.
16. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292:344-347.
17. Hoogendijk JE, Amato AA, Lecky BR etal. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004; 14:337-345.
18. Isenberg DA, Allen E, Farewell V etal. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology 2004; 43:49-54.
19. Okiyama N, Sugihara T, Oida T etal. T lymphocytes and muscle condition act like seeds and soil in a murine polymyositis model. Arthritis Rheum 2012; 64:3741-3749.
20. Posnett DN, Edinger JW, Manavalan JS, Irwin C, Marodon G. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones. Int Immunol 1999; 11:229-241.
21. Antiga E, Kretz CC, Klembt R etal. Characterization of regulatory T cells in patients with dermatomyositis. J Autoimmun 2010; 35:342-350.
22. Chevrel G, Page G, Miossec P. Novel aspects on the contribution of T cells and dendritic cells in the pathogenesis of myositis. Autoimmunity 2006; 39:171-176.
23. Viguier M, Fouere S, de la Salmoniere P etal. Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. Medicine (Balt) 2003; 82:82-86.
24. + lymphocyte subsets in systemic lupus erythematosus patients with lymphopenia. Clin Exp Immunol 2011; 164:17-25.
25. Amasaki Y, Kobayashi S, Takeda T etal. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. Clin Exp Immunol 1995; 99:245-250.
26. Tournadre A, Lenief V, Miossec P. Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines. Arthritis Rheum 2010; 62:2144-2151.
27. Moran EM, Mastaglia FL. The role of interleukin-17 in immune-mediated inflammatory myopathies and possible therapeutic implications. Neuromuscul Disord 2014; Jun 20. pii: S0960-8966(14)00583-5. doi: 10.1016/j.nmd.2014.06.432. [Epub ahead of print].
28. Moran EM, Mastaglia FL. Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications. Clin Exp Immunol 2014; 178:405-415.
29. Tang X, Tian X, Zhang Y etal. Correlation between the frequency of Th17 cell and the expression of microRNA-206 in patients with dermatomyositis. Clin Dev Immunol 2013; 2013:1-7.
30. Tournadre A, Porcherot M, Cherin P, Marie I, Hachulla E, Miossec P. Th1 and Th17 balance in inflammatory myopathies: interaction with dendritic cells and possible link with response to high-dose immunoglobulins. Cytokine 2009; 46:297-301.
31. Banica L, Besliu A, Pistol G etal. Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity 2009; 42:41-49.
32. Allenbach Y, Solly S, Gregoire S etal. Role of regulatory T cells in a new mouse model of experimental autoimmune myositis. Am J Pathol 2009; 174:989-998.
33. Zelenay S, Lopes-Carvalho T, Caramalho I, Moraes-Fontes MF, Rebelo M, Demengeot J. Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci USA 2005; 102:4091-4096.
34. Simpson N, Gatenby PA, Wilson A etal. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum 2010; 62:234-244.
35. King IL, Mohrs M. IL-4-producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cells. J Exp Med 2009; 206:1001-1007.
36. Fasth AE, Snir O, Johansson AA etal. Skewed distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis. Arthritis Res Ther 2007; 9:R87.
37. Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R. CD4+CD28- costimulation-independent T cells in multiple sclerosis. J Clin Invest 2001; 108:1185-1194.
38. Eloranta ML, Barbasso Helmers S, Ulfgren AK, Ronnblom L, Alm GV, Lundberg IE. A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies. Arthritis Rheum 2007; 56:3112-3124.
39. Reed JR, Vukmanovic-Stejic M, Fletcher JM etal. Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med 2004; 199:1433-1443.
40. Appay V, Dunbar PR, Callan M etal. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-385.